Both in Pharmaceuticals
Alnylam Pharmaceuticals vs BridgeBio Pharma
Over the past year ALNY returned −63.8% and BBIO returned +19.7%; their daily moves had a correlation of 0.20.
ALNY −63.8% BBIO +19.7%Growth of $1, one year, split-adjusted
| Metric | ALNY | BBIO |
|---|---|---|
| Price | $165.00 | $74.95 |
| Market cap | $22.10B | $14.60B |
| Today | −5.17% | +5.97% |
| 1 month | −28.6% | +12.0% |
| 6 months | −44.3% | +9.3% |
| Year to date | −58.5% | −2.0% |
| 1 year | −65.7% | +12.5% |
| Revenue growth (YoY) | +16.7% | +192.6% |
| Gross margin | 75.2% | 94.2% |
| Net margin | 148.6% | −23.5% |
| P/E (TTM) | 8.1× | — |
| Price / sales | 4.4× | 15.4× |
| Net cash | $2.57B | -$938.6M |
| Dividend yield | — | — |
| Volatility (60d) | 72.5% | 32.7% |
| Short % of float | 4.9% | 12.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).